1-phenyl-2-(N-2-propynyl)aminopropane,
demethyl-deprenyl-DMD,
demethyldeprenyl-selegiline,
desmethyldeprenyl,
desmethylselegiline,
desmethylselegiline hydrochloride,
desmethylselegiline, (+)-isomer,
desmethylselegiline, (+-)-isomer,
desmethylselegiline, (-)-isomer,
di-N-propargylamphetamine,
N-desmethyl-selegiline,
Nordeprenyl,
Desmethyldeprenyl,
18913-84-3,
Desmethylselegiline,
Demethyl-deprenyl-dmd,
N-Desmethyl-selegiline,
Di-N-propargylamphetamine,
Demethyldeprenyl-selegiline,
1-Phenyl-2-(N-2-propynyl)aminopropane,
alpha-Methyl-N-2-propynylbenzeneethanamine,
UUFAJPMQSFXDFR-UHFFFAOYSA-N,
Benzeneethanamine, alpha-methyl-N-2-propynyl-,
Propargylanara,
Propargylamphetamine,
N-propargylamphetamine,
N-Desmethyl Selegline,
AC1L44XS,
CHEMBL1276,
SCHEMBL4543249,
CTK8G1990,
AKOS012315520,
Methyl Prop-2-ynyl-2-phenylethylamine,
1-phenyl-N-prop-2-ynylpropan-2-amine,
MCULE-1120354174,
ACM18913843,
BBV-36839407,
LS-173750,
FT-0673065,
EN300-146886,
Benzeneethanamine, alpha-methyl-N-2-propyn-1-yl-,
N-(1-Methyl-2-phenylethyl)-2-propyn-1-amine #,
J-012201,
(+/-)-N-Desmethylselegiline solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,
Manganese disalicylate,
C12H15N,
C12-H15-N,
CID200718,
|A-Methyl-N-2-propynylphenethylamine,
|A-Methyl-N-2-propynylbenzeneethanamine,